KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

September 28, 2018

Study Completion Date

October 18, 2018

Conditions
Ocular Inflammation
Interventions
DRUG

KPI-121 1%

eye drops

DRUG

Prednisolone acetate

eye drops

Trial Locations (4)

16501

Pediatric Ophthalmology of Erie, Inc., Erie

48201

Children's Eye Care, PC, Detroit

77380

Houston Eye Associates, The Woodlands

94303

Byers Eye Institute at Stanford University, Palo Alto

Sponsors
All Listed Sponsors
lead

Kala Pharmaceuticals, Inc.

INDUSTRY

NCT03596723 - KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children | Biotech Hunter | Biotech Hunter